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Hypoxic tumours are a major problem for cancer photodynamic therapy. Here we show that 
photo-redox catalysis can provide an oxygen-independent mechanism of action to combat 
this problem. We have designed a highly oxidative Ir(III) photo-catalyst, [Ir(ttpy)(pq)Cl]PF6 
([1]PF6, ttpy = 4'-(p-tolyl)-2,2':6',2''-terpyridine, pq = 3-phenylisoquinoline), which is photo-
toxic towards both normoxic and hypoxic cancer cells. Complex 1 photo-catalytically 
oxidizes nicotinamide adenine dinucleotide (NADH), an important coenzyme in living cells, 
generating NAD• radicals with high turnover frequency in biological media. Moreover, 
complex 1 and NADH synergistically photo-reduce cytochrome c under hypoxia. Density 
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functional theory calculations reveal -stacking in adducts of 1 and NADH, facilitating 
photo-induced single electron transfer. In cancer cells, 1 localizes in mitochondria and 
disrupts electron transport via NADH photo-catalysis. Upon light irradiation, 1 induces 
NADH depletion, intracellular redox imbalance, and immunogenic-apoptotic cancer cell 
death. This photo-catalytic redox imbalance strategy offers a new approach for efficient 
cancer phototherapy. 
Platinum compounds are the most widely used anticancer drugs in the clinic1. However, new 
generations of metal-based anticancer agents are urgently needed to combat drug resistance 
and reduce side-effects2,3. Photo-activated metal complexes can provide both temporal and 
spatial control over drug activation and show remarkable potential for cancer treatment4-8. 
Tin, lutetium, palladium and ruthenium based photosensitizers (PSs) are, or were, currently in 
clinical trials for cancer photodynamic therapy (PDT)9,10. The catalytic nature of PDT can 
achieve high therapeutic efficacy at low doses11, and, in general, does not show cross 
resistance to chemotherapy, helpful for overcoming drug resistance12.  However, a few cases 
of clinical resistance to PSs are emerging13-21.The mechanisms of PDT resistance include 
hypoxia13, detoxification by intracellular antioxidant systems,14,15 induction of stress response 
genes,16-20 and drug efflux by P-glycoprotein21. These considerations indicate the urgency of 
developing new generations of PSs and novel mechanisms of action (MOA) for cancer 
phototherapy. The high dependence of the MOA of PDT on oxygen restricts its application, 
since cancer cells grow mostly under hypoxia22. We have therefore investigated novel PSs 
with new MOAs against hypoxic cancer cells. 
Although most tumours adopt a Warburg-type glycolytic metabolism, Reactive Oxygen 
Species (ROS) released from the mitochondrial electron transport chain (ETC) are essential 
for cell proliferation and redox regulatory functions of cancer cells under hypoxia23. The 
electron source in the ETC is 1,4-dihydronicotinamide adenine dinucleotide (NADH, Fig. 
1a), which participates in the maintenance of the intracellular redox balance and as a 
coenzyme in >400 oxidoreductases24. We hypothesise that selective induction of NADH 
depletion and of ETC disruption in cancer cells may destroy the intracellular redox balance 
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and kill cancer cells under hypoxia. 
Photo-catalysts which induce single electron transfer (SET) between substrates have 
achieved great success in organic synthesis25. It is notable that most reported photoredox 
catalysis has been carried out in degassed organic solvents26. An oxygen-independent MOA 
is appealing for NADH photo-catalysis in hypoxic cancer cells. However, strong triplet 
excited-state quenching by water and oxygen severely limits the application of traditional 
photo-catalysts in biological systems27.  
Here we have synthesised and characterised a novel stable iridium photo-catalyst (1, Fig. 
1b) with an unusually high excited state reduction potential compared to common PSs25. 
Strikingly, upon light irradiation in biological media, complex 1 shows more than two orders 
of magnitude higher NADH oxidation turnover frequency (TOF) than organometallic half-
sandwich catalysts28. Moreover, 1 can photo-catalyse cytochrome c (cyt c) reduction in the 
presence of NADH under hypoxia. We have carried out detailed experimental and 
computational studies on photo-catalytic NADH oxidation in aqueous media, involving the 
trapping of NAD radicals and their characterisation. In addition, complex 1 targets 
mitochondria in cancer cells, and, importantly, shows almost equivalent photo-cytotoxicity 
under normoxia and hypoxia, as well as low toxicity to unirradiated normal cells. 
 
Results  
Photosensitizer design and characterisation 
Complex 1 was characterised by analytical and spectroscopic data, and x-ray crystallography 
(Fig. 1c, Supplementary Tables 1, 2). Ir(III) photoredox catalysts with bidentate ligands often 
exist as a mixture of enantiomers29. The incorporation of tridentate ligands can avoid 
chirality30, as in the present case (Fig. 1c). Density functional theory (DFT）calculations 
confirmed that the  
 
 
 
4 
 
trans C-Cl isomer found in the crystal structure is 33.5 kJ mol-1 more stable than the cis C-Cl 
isomer. Complex 1 showed absorption between 350-480 nm (Supplementary Fig. 1), which 
matched well with spectra calculated by time-dependent DFT (TD-DFT; Supplementary Fig. 
2), with low-lying metal-to-ligand charge-transfer states (MLCT, Supplementary Table 3).  
The phosphorescence of complex 1 was sensitive to solvent polarity (Supplementary Fig.3, 
Supplementary Table 4) with emission at ca. 562 nm similar to the calculated data (567 nm, 
Supplementary Table 3) at 293 K. Moreover, oxygen strongly influenced the 
phosphorescence intensity and lifetime of 1 (Supplementary Figs. 4,5, Supplementary Table 
4), being longer in acetonitrile (743.7/1390.3 ns, air/N2) than in phosphate buffered saline 
(PBS, 330.8/382.3 ns, air/N2). The lowest energy singlet excited state S1 arises from LUMO 
 HOMO excitation and showed both ligand-to-ligand charge-transfer and MLCT character 
(Supplementary Table 3, Supplementary Fig. 6). Upon light excitation, the excited triplet 
transition “hole” (Fig. 2a) is localised on the -system of the C^N ligand, while the 
“particle” is localised on the N^N^N ligand. In addition, complex 1 exhibited strong two-
photon absorption (TPA) (Fig. 2b), observed with a maximum at ca. 760 nm (Supplementary 
Fig. 7) and a two-photon absorption cross section of 160 Goeppert-Mayer (GM).  
 
 
Ideally, efficient photo-catalytic drugs should exhibit high dark- and photo-stability. 
Complex 1 showed excellent stability in both organic solvents, e.g. DMSO (Supplementary 
Fig. 8), RPMI-1640 cell culture medium (Fig. 2c), and human serum (Supplementary Fig. 9) 
on prolonged incubation. Additionally, 1 also exhibited no photo-degradation under 463 nm 
blue-light irradiation in PBS (Fig. 2d).  
Cyclic voltammetry revealed a significantly different redox behavior in the ground and 
excited states of 1 (Supplementary Table 5). The excited-state reduction potential of 1 
(E1/2*III/II = +1.22 V vs SCE) is higher than for reported Ru(II) or Ir(III) photocatalysts 
(Supplementary Fig. 10, Supplementary Table 5)25. DFT calculations also confirmed that the 
triplet excited state of 1 switched character with the ground state (Supplementary Fig. 11) in 
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terms of reductant-to-oxidant behavior (Supplementary Table 6), and thus is a strong excited-
state oxidant (Supplementary Table 7). 
 
Photo-catalytic oxidation of NADH under normoxia 
The catalytic photo-oxidation of NADH (3 mM) by 1 (0.25 mM) in H2O/D2O/CD3OD 
(0.5/49.5/50, v/v, 4 mM NaCl) was monitored by 1H NMR spectroscopy at 298 K. In the dark, 
the sample remained unchanged for 24 h. In contrast, ca. 95% of the NADH was oxidised to 
NAD+ after irradiation (463 nm, 30 min), while 1 remained intact (Supplementary Fig. 12). 
The photo-catalytic efficiency of 1 (6 M) towards NADH (240 M) in PBS was 
quantified by UV-vis spectroscopy (Supplementary Fig. 13). Upon photoirradiation (463 nm) 
in air, the absorbance of NADH at 339 nm decreased gradually (Fig. 3a), and the conversion 
of NADH to NAD+ was confirmed by mass spectrometry (Supplementary Fig. 14). A plot of 
lnA339 versus time revealed first-order kinetics with a rate constant k of 1.77  10-2 min-1 
(Supplementary Fig. 15). The highest observed NADH oxidation turnover number (TON) 
was 50.2 with a turnover frequency (TOF) of 100.4 h-1 (Supplementary Table 8), much higher 
than the reported (non-photoactivated) Ir(III) half-sandwich catalyst [(5-
Cpxbiph)Ir(phpy)py]PF6 (TON=7.6 after 20 h)28. Moreover, complex 1 was stable during long-
term photo-catalysis (2 h, Supplementary Fig. 16). Importantly, the reaction rate was not 
affected by NaN3 (1O2 scavenger), and was similar in deionised water (Supplementary Fig. 
13). After irradiation of 1 and NADH in PBS in air, H2O2 was generated as detected by 
peroxide detection strips (Fig. 3a), and the pH of the reaction solution increased by ca. 2 units 
(Supplementary Fig. 17). 
A Stern−Volmer titration31 was used to study the mechanism of the photcatalytic oxidation 
of NADH. When the NADH concentration was increased, the phosphorescence intensity of 
1 decreased gradually with a dynamic quenching rate coefficient of 6.8  106 (Fig. 3b). The 
phosphorescence lifetime of 1 in air-saturated PBS (330 ns) decreased by ca. 50% after 
addition of NADH (171 ns, Supplementary Fig. 5). 
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Electron paramagnetic resonance (EPR) was used to trap radical intermediates during 
photo-catalytic oxidation of NADH (Fig. 3c) using 5-(2,2-dimethyl-1,3-propoxycyclo-
phosphor-yl)-5-methyl-1-pyrroline-N-oxide (CYPMPO) as the spin trap32. In the presence of 
CYPMPO, a carbon-centred NAD• radical was detected as CYPMPO-NAD together with 
CYPMPO-CH3 after irradiation in PBS/methanol (1:1 v/v, 463 nm, 10 min, 293 K). The CH3 
radical was generated by a photo-reaction between H2O2 and methanol (Supplementary Fig. 
18). Singlet oxygen production was also detected by EPR, and the quantum yield in 
acetonitrile (0.71) was 7x higher than in PBS ( = 0.11; Supplementary Fig. 19). This is due 
to the longer lifetime of the triplet state in acetonitrile compared to PBS, typical for metal 
complexes having a triplet excited state7,9. 
Molecular adducts of NADH and excited-state *1 were investigated by DFT calculations. 
Stable minima were observed for structures with NADH clamped by - interactions over the 
triplet hole orbital localized on the pq ligand (Fig. 3d), and over the triplet particle orbital 
localized on the ttpy -system (Fig. 3e), structures which would facilitate electron transport 
from NADH to *1. 
 
Photoreduction of cytochrome c under hypoxia 
Under nitrogen, the photo-catalytic activity of 1 decreased significantly compared to under 
air (TON = 3.8, Supplementary Fig. 20) due to the absence of a terminal electron acceptor. In 
the mitochondrial electron transport chain (ETC), the 12.3 kDa heme protein cyt c transfers 
electrons between Complex III (Coenzyme Q-cyt c reductase) and Complex IV (cyt c 
oxidase)33. Release of cyt c from the mitochondria into the cytoplasm induces cell apoptosis34.  
 The oxidation state of cyt c (Fe2+/Fe3+) can readily be monitored by the  and  bands at 
520 and 550 nm, respectively35. NADH (50 M) slowly reduced Fe3+-cyt c (11.2 M; 293 K, 
Supplementary Fig. 21). The reaction was slightly accelerated upon 463 nm light irradiation 
(Supplementary Fig. 21) with low TOF (2.8 h-1, Supplementary Fig. 22). In the absence of 
NADH, 1 (0.6 M) did not reduce Fe3+-cyt c, even under light irradiation (Supplementary Fig. 
21). After adding NADH, the rate of photo-reduction of Fe3+-cyt c increased significantly 
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(Fig. 3f), with the TOF increasing to 16.7 h-1. When CYPMPO was added to trap NAD, the 
reduction rate decreased (Supplementary Figs. 21, 22), indicating that NAD  was involved in 
Fe3+-cyt c photoreduction.   
 
Photo-cytotoxicity and cell death mechanism 
The dark- and photo-cytotoxic activity of 1 was investigated against a range of cancer cell 
lines, and normal cells MRC-5 (human lung fibroblasts) and LO2 (human hepatocyte cell 
line), (Supplementary Figs. 23-26, Supplementary Table 9). Cisplatin and 5-aminolevulinic 
acid (5-ALA) were used as controls (Supplementary Fig. 24). Low dark toxicity was 
observed for both A549 human lung carcinoma (IC50 43.6 µM) and MRC-5 cells (43.2 µM) 
after 2 h drug exposure and 46 h recovery. Complex 1 also showed low dark toxicity towards 
normal LO2 human hepatocyte cells (IC50 = 32 µM). For photo-cytotoxicity screening, A549 
cells were treated with 1 for 2 h, washed, placed in fresh medium, then irradiated with blue 
light for 30 min under normoxia (20% O2, 465 nm, 8.9 J/cm2) or hypoxia (1% O2, 450 nm, 10 
J/cm2), and left for 46 h to recover. Under normoxia, 1 (1.6 µM) exhibited high photo-
cytotoxicity with a photo-cytotoxicity index (PI = dark IC50/light IC50) of 27.2. Interestingly, 
1 exhibited similar photo-cytotoxicity (dark/light 42.5/2.3 M, PI = 18.5) under hypoxia. In 
addition, we found that complex 1 is active against NCI-H460 (lung), HeLa (cervix), Hep G2 
(liver) and SGC-7901 (gastric) cancer cell lines upon light irradiation under both 20% and 
1% oxygen concentrations with sub-micromolar IC50 values (Supplementary Table 9, 
Supplementary Fig. 23). However, the clinical pro-drug 5-ALA, a precursor of the 
photosensitizer protoporphyrin, was totally inactive under hypoxia after irradiation 
(Supplementary Table 9, Supplementary Fig. 24). The photo-cytotoxicity of complex 1 under 
normoxia was reduced in the presence of NaN3 (1O2 scavenger) and D-mannitol (hydroxyl 
radical scavenger) for A549 cells. However, these ROS inhibitors had no significant 
influence on photo-cytotoxicity under hypoxia (Supplementary Fig. 25, Supplementary Table 
9), suggesting a different cellular response to photo-catalysis. It should be noted that 
cytotoxicity experiments are very sensitive to experimental conditions, including incubation 
time, irradiation time, light dose, and mode of treatment. Changes in the cytotoxicity of 1, 
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cisplatin and 5-ALA were observed with change in the incubation time and mode of 
treatment. As most of complex 1 was taken up by the cells within 2 h of incubation time, in 
all our photocytotoxicity experiments, 2 h of incubation with 1 was used prior to 
photoirradiation. 
To investigate the phototherapeutic efficiency on a solid tumour model, the photo-
cytotoxicity of 1 towards A549 lung cancer multicellular spheroids (MCS)36 of diameter ca. 
800 µm was studied (Supplementary Fig. 27, Supplementary Table 9). Remarkably, using 
two-photon red light irradiation (760 nm, 12 J/cm2), 1 gave a PI of 9.7 (dark/light 12.6/1.3 
M). Under the same conditions, 5-ALA and cisplatin did not exhibit any significant photo-
cytotoxicity37. 
Inductively coupled plasma-mass spectrometry (ICP-MS) confirmed the high cellular 
uptake of 1 (162  6 ng Ir × 106 cells, 5 M treatment, 2 h,). Furthermore, co-localization 
imaging and quantification by ICP-MS38 (Fig. 4a and Supplementary Fig. 28) showed that ca. 
90% of Ir from 1 localized in mitochondria. Importantly, pulsed laser phosphorescence 
lifetime imaging39 (Fig. 4b) revealed that 1 has an extremely long phosphorescence lifetime 
in A549 cancer cells (1100 ns, Supplementary Fig. 29). 
Next, we investigated photo-induced intracellular NADH depletion in A549 cells. Under 
normoxia, the intracellular NADH concentration was unaffected after incubation with 
increasing concentrations of 1 in the dark (Fig. 4c). Upon light irradiation, 1 induced a 
dramatic depletion in NADH (ca. 4x at 2 M) and decreased the concentration of adenosine 
triphosphate (ATP) (Fig. 4d). In addition, the irradiated cells lost their ability to generate 
formazan from 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), a 
reaction which requires NAD(P)H-dependent oxidoreductase enzymes (Supplementary Fig. 
30)40.  
We also explored cellular oxidative stress induced by 1. After light irradiation, a strong 
green fluorescence was observed from the ROS probe DCFH-DA under both normoxia and 
hypoxia (Supplementary Fig. 31). A549 lung cancer multicellular spheroid models (ca. 800 
m in diameter) showed that ROS were generated only in the outer regions of the MCS after 
irradiation with 760 nm two-photon light (Supplementary Fig. 32), indicating the formation 
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of a hypoxic core in the internal region of the spheroids. These results suggested that 
diffusible ROS species41 such as H2O2 were generated. Indeed, the intracellular H2O2 
concentration increased ca. 2.5x (Fig. 4e) compared to unexposed cells. Moreover, the 
cellular H2O2 concentration was significantly lower in the presence of N-acetyl-L-cysteine 
(Fig. 4f), a known ROS scavenger42.  
 
A decrease in the mitochondrial membrane potential (MMP) was observed in 1-treated 
A549 cells after irradiation under both normoxia and hypoxia (Supplementary Figs. 33, 34), 
indicating disruption of the mitochondrial ETC43. However, 1 did not induce any significant 
change in MMP in MRC-5 normal cells in the dark. Furthermore, staining of cells with the 
green fluorescent FTIC-Annexin V conjugate was observed (Supplementary Fig. 35), 
indicating cell apoptosis. Moreover, these cells also showed red fluorescence on co-staining 
with propidium iodide (PI). Apoptotic cells would not allow PI to enter cells, and hence cell 
death may involve an immunogenic-apoptotic mechanism44. We also performed cell 
membrane calreticulin immunofluorescence and an Enzyme-linked Immunosorbent Assay 
(ELISA) for high mobility group box 1 protein (HMGB1) (Supplementary Fig. 36). 
Calreticulin transfer to the outer cell membrane and release of HMGB1 are well known 
markers of immunogenic cell death44. Calreticulin transfer to the outside of the cell 
membrane, detected by Alexa Fluor 488 linked calreticulin antibody, was observed in the 1-
treated A549 cancer cells upon light irradiation. We also detected release of HMGB1 at the 
same time. Both these findings, along with the Annexin V /PI assay, confirmed that complex 
1 induces immunogenic-apoptotic cell death upon light irradiation. 
 
Discussion 
Catalytic metallodrugs activated at low doses have the potential to increase the efficacy of 
cancer therapy45. However, controlling catalytic activity in complicated tissue and cell 
environments as well as selectivity between normal and cancer cells is extremely challenging. 
In contrast to chemotherapy, PDT provides light-directed cancer-cell-targeted treatment and 
can avoid drug resistance12. However, cancer cells grow under hypoxia and thus the oxygen-
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dependent MOA of PDT remains a problem, as is photo-degradation of photosensitisers46. 
Hence we have now designed a stable photo-redox catalyst with an oxygen-independent 
MOA as a new strategy to overcome these problems. 
Our photo-redox catalytic approach recognises two key vulnerabilities in cancer cells. 
Firstly, the mitochondrial ETC contributes to tumourigenic phenotype amplification, cell 
proliferation, and especially cell survival under hypoxia23. Secondly cancer cells are under 
constant oxidative stress47. Coenzyme NADH not only provides electrons for the ETC, but 
also maintains the cellular redox balance and participates in enzyme reactions24. Photo-
catalytic NADH depletion and ETC disruption can therefore achieve selective attack on 
cancer cells and high anticancer activity under hypoxia. 
The novel octahedral Ir(III) photocatalyst 1 was synthesised as a single isomer driven by 
the tridentate ligand ttpy. The X-ray structure and DFT calculations show formation of the 
trans C-Cl isomer, with the negatively-charged C ligand exerting a strong trans influence on 
the Ir-Cl bond. The special ligand coordination architecture tunes the Ir(III) coordination 
sphere, and ensures well-partitioned HOMO and LUMO within the structure, thus 
significantly enhancing dark- and photo-stability48. In contrast, the Ir(III) photo-catalyst 
[Ir(ppy)2(bpy)]+ (ppy = 2-phenylpyridine, bpy = 2,2'-bipyridine) is not photo-stable and 
undergoes photodecomposition during long-term light irradiation49. Moreover, the presence 
of a single cyclometalated chelated ligand decreases the electron density at Ir(III), thereby 
significantly increasing the excited-state reduction potential of 1.   
NADH oxidation is usually associated with one-step hydride transfer to substrates, as 
observed for example in transfer hydrogenation using Cp*-iridium(III) catalysts28. However, 
initial one-electron transfer is also known50, e.g. in thermal reactions of [Ru(bpy)3]3+ with 
NADH analogues BNAH (1-benzyl-1,4-dihydronicotinamide)51, and UVA-induced electron 
transfer from NADH to generate superoxide for DNA cleavage52. Other reports have also 
used NADH as an electron donor in photosensitisation53; however, electron transfer between 
a PS and NADH has been little investigated. Our DFT calculations reveal the formation of 
“clamped” - adducts between excited-state *1 and NADH which can facilitate photo-
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induced single electron transfer. As a result, complex 1 achieves high TOF for catalytic 
NADH oxidation (100.4 h-1) on light irradiation.  
The mechanism of the photo-catalytic oxidation of NADH is consistent with the reductive 
quenching cycle shown in Figure 5. Upon light excitation, the highly oxidative excited state 
species *1(IrIII) extracts an electron from 1,4-dihydronicotinamide, forming a highly reductive 
1(IrII) species and NADH+ radicals. NADH+ readily deprotonates to generate the neutral 
carbon-centred NAD radical. Under normoxia (Figure 5a), oxygen oxidises 1(IrII) to form 
superoxide radicals and regenerates 1(IrIII), completing the photo-catalytic cycle. The 
superoxide radical extracts an electron from NAD  and consumes two protons from the 
medium as evidenced by the pH increase, forming H2O2 and NAD+. Under hypoxia, Fe3+-cyt 
c is a terminal electron acceptor (Figure 5b). In previous reports, Ru(II)/Ir(III) bis-terpyridyl 
complexes and EDTA radicals exhibited a synergistic effect on Fe3+-cyt c reduction54, 
whereas here, we discovered that NADH can also serve as a biological electron donor in the 
synergistic reduction of Fe3+-cyt c by complex 1 or the related complex [Ir(tpy)2]3+ 
(Supplementary Fig. 22). Thus, we confirmed that photo-reduction of Fe3+-cyt c can arise 
from the synergistic action of NAD radicals and the highly reducing IrII species in a 
deoxygenated environment. This pathway provides a mechanism for oxygen-independent 
NADH depletion with its downstream effects on a wide variety of cellular redox enzymes and 
pathways, and plays an important role in hypoxic photoredox catalysis in cancer cells. 
 
Although mitochondria are dysfunctional in cancer cells, ROS released from the ETC 
under hypoxia are essential for cancer cell survival and redox regulatory functions55. In our 
system, complex 1 induces significant NADH depletion and ETC disruption only in 
irradiated cancer cells, as indicated by the MMP decrease under both normoxia and hypoxia. 
Moreover, ROS generation in cancer cells indicates oxygen consumption during photo-
catalysis by 1 which can cut off essential mitochondrion-to-cell redox communication for cell 
survival under hypoxia56.  These events lead to the induction of cell apoptosis and necrosis by 
complex 1, features of immunogenic apoptosis57. Calreticulin immunofluorescence and 
HMGB1 ELISA assays confirmed this hypothesis44. Immunogenic cell death provides a 
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potentially powerful strategy for anticancer therapy58, reinstating the body’s defense against 
cancer.  
In addition, both DFT calculations and experimental data reveal strong near infrared two-
photon absorption of 1, and we have demonstrated promising phototherapeutic effects on 
A549 multicellular lung cancer spheroids. These one-photon and two-photon light activation 
properties of 1 will facilitate a broad application from superficial lesions to solid tumours.  
 
Conclusions 
We report for the first time both aqueous and in-cell photo-catalytic oxidation of coenzyme 
NADH by a metal complex, with a very high TOF. The novel octahedral cyclometalated IrIII 
photoredox catalyst, complex 1, is highly photostable with a long phosphorescence lifetime. 
This catalyst, with its unusually high excited state reduction potential, not only generates 
NAD. radicals, but also perturbs electron transfer pathways in mitochondria by reduction of 
Fe3+-cytochrome c, inducing redox imbalance in cancer cells. The photoredox catalyst is 
equipotent towards normoxic and hypoxic adherent cancer cells, disrupting the mitochondrial 
membrane potential and inducing immunogenic apoptotic cell death. In contrast, current 
clinical photo-chemotherapeutic agents are less effective in hypoxic environments. Moreover, 
photo-catalyst 1 exhibits low toxicity towards normal cells in the dark, a favorable profile for 
reducing the side-effects of treatment. Complex 1 with its photo-controlled oxygen-
independent immunogenic-apoptotic mechanism of cancer cell death is promising for further 
evaluation as a novel targeted anticancer agent.  
 
Methods 
UV-vis studies of complex 1 and NADH reactions. Reactions between complex 1 and 
NADH in various mol ratios were monitored by UV-vis spectroscopy at 310 K in the dark 
and on irradiation with 463 nm light. Turnover number (TON) is defined as the number of 
moles of NADH that a mole of complex 1 can convert within 30 min. Turnover frequency 
(TOF) was calculated from the difference in NADH concentration after 30 min divided by the 
concentration of complex 1. The concentration of NADH was obtained using the extinction 
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coefficient ε339 = 6220 M-1cm-1. 
 
Electron paramagnetic resonance (EPR). EPR spectra were recorded at ambient 
temperature (ca. 293 K) on a Bruker Model A300 ESR spectrometer equipped with a Bruker 
ER 4122 SHQ resonator using 1.0 mm quartz tubes. Typical instrument settings were: 
modulation amplitude 2.0 G and microwave power 0.63 mW, X-band frequency ca. 9.88 
GHz. Spectra were acquired at 20 dB microwave attenuation (non-saturating 2 mW 
microwave power) with modulation amplitude of 0.2 mT peak-to-peak, time constant of 1.28 
ms, receiver gain, 50–200; sweep time, 30 s and conversion time of 5.12 ms. The spin trap 5-
(2,2-dimethyl-1,3-propoxycyclo-phosphoryl)-5-me-thyl-1-pyrroline N-oxide (CYPMPO 1 
mM) was used for NAD radicals in PBS/methanol (1:1 v/v) containing complex 1 (500 M, 
methanol) and NADH (10 mM, PBS) under 463 nm irradiation. 
 
Electrochemistry 
Cyclic voltammograms were recorded using a CH Instrument model 600D Electrochemical 
Analyzer/Workstation (Austin, TX). The electrochemical measurements were performed on 
complex 1 (1.0 mM) in acetonitrile solutions containing tetrabutylammonium 
hexafluorophosphate (0.1 M) as supporting electrolyte. The solutions were degassed under 
nitrogen and cyclic voltammograms were scanned from -2.3 V to +2.3 V (three complete 
scans for each experiment). In a typical electrochemical experimental set up, a three-electrode 
system was used: a glassy carbon electrode as the working electrode, saturated calomel 
electrode as the reference electrode, and platinum wire as the counter electrode. CV was 
performed at a scan rate of 100 mV/s. The excited state redox potentials were calculated from 
the ground state redox potentials and the emission maxima to aid evaluation of the 
photosensitization properties of complex 1. Excited state reduction potentials: E([M*]+ 
/[M]2+) = Eox − Eλem. Excited state oxidative potentials: E([M*]+ /[M]0 ) = Ered + Eλem. Eλem = 
1240 eV nm /em. 
 
Data availability 
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The data that support the findings of this study are available within the paper and its 
Supplementary Information files, or from the corresponding authors on reasonable request. 
Crystallographic data for the complex [1]PF6ꞏ(1.5 toluene) reported in this Article have been 
deposited at the Cambridge Crystallographic Data Centre, under deposition numbers CCDC 
1840366). After the Open Access agreement has been established, underpinning datasets will 
be deposited in Warwick's Institutional Repository: Warwick Research Archive Portal 
(WRAP), according to the Open Access Agreement. 
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Figure 1. Structures of compounds. a) NADH. b) Complex 1, line structure, and c) X-ray 
crystal structure; the counter ion PF6- has been omitted for clarity. 
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Figure 2. DFT calculations and stability of complex 1. a) Dominant canonical particle-hole 
orbitals with overall contribution to the lowest first triplet state of 1. b) Dominant canonical 
particle-hole orbital representation of the strong TPA intermediate state by non-resonant 3-
state model. c) UV-vis spectra showing the dark stability of 1 in RPMI-1640 cell culture 
medium at 293 K for 24 h. The experiment was repeated three times independently with 
similar results. d) Photostability of the emission of 1 in PBS under continuous 463 nm light 
irradiation for 30 min at 293 K. The experiment was repeated three times independently with 
similar results. 
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Figure 3 Photoredox reaction between NADH and complex 1 under 463 nm blue-light 
irradiation. a) Photo-catalytic oxidation of NADH (240 M) by complex 1 (6 M) in PBS 
monitored by UV-vis spectroscopy; inset: detection of H2O2 after irradiation (D = dark, L = 
light). The coloured lines represent spectra recorded every 5 min for 0.5 h. The direction of 
change in absorbance with time is indicated by red arrows. The experiment was repeated five 
times independently with similar results. b) Stern−Volmer plot showing NADH interacts with 
the excited state of complex 1. The experiment was repeated three times independently with 
similar results. c) X-band EPR spectrum of NAD radicals trapped by CYPMPO at various 
times after irradiation with 463 nm light: CYPMPO-NAD (blue circles, N = 14.43 G, H = 
20.35 G, P = 50.72 G), CYPMPO-CH3 (red circles, N = 14.67 G, H = 20.25 G, P = 48.92 
G, where α is the hyperfine coupling constant for coupling of the unpaired electron with 14N, 
1H or 31P, where 14, 1 and 31 are superscripts). The experiment was repeated five times 
independently with similar results. d) Optimized DFT stable minima for NADH-1 (triplet 
state) structures with NADH clamped around pq or e) ttpy ligands. f) Photo-catalytic 
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reduction of oxidised cyt c (11.2 M) by NADH (50 M) and complex 1 (0.6 M), inset: 
dependence of absorbance at 550 nm on irradiation time. R^2 is the coefficient of 
determination (goodness of fit). The experiment was repeated three times independently with 
similar results. 
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Figure 4 Cellular localization and cellular response after irradiation. a) One- and two-
photon images of A549 lung cancer cells treated with 1 (5 M) for 1 h and co-stained with 
mitochondrial and lysosomal dyes. ex/em: 1 405/562 nm, lysotracker 488/520 nm, 
mitotracker 633/660 nm. The experiment was repeated three times independently with similar 
results. b) Phosphorescence lifetime images of living A549 cells treated with 1 (5 M), 
ex/em: 760/562 nm. The experiment was repeated twice independently with similar results. c) 
NADH concentration, d) ATP concentration, and e) H2O2 concentration, in A549 cells treated 
with various doses of 1 in the dark or light. f) H2O2 concentration in A549 cells after light 
irradiation in the presence or absence of 5 mM N-acetyl-L-cysteine (NAC; cell exposure to 1 
for 2 h, washed, followed by 465 nm light irradiation 8.9 J/cm2). RLU: relative luminescence 
unit. Figure 4c-4f: All the experiments were performed as duplicates of triplicates (n=6 
biologically independent experiments). Error bars show ±1 s.d. from the mean. Statistics were 
calculated using the two-tailed t-test with unequal variances (Welch’s unpaired t-test) by 
comparing sample treated with the same dose in the presence or absence of light irradiation. 
*p < 0.05, **p < 0.01 ***p < 0.001. p values:  
4c: NADH 0.5 µM (p = 0.0029), 1.0 µM (p = 0.0003), 2.0 µM (p = 0.0002) 
4d: ATP light 1.0 µM (p = 0.0132), 2.0 µM (p = 0.0052) 
4e: H2O2 0.5 µM (p = 0.0048), 1.0 µM (p = 0.0025), 2.0 µM (p = 0.0009) 
4f: +NAC 0.0 µM (p = 0.0009), 0.5 µM (p = 0.0003), 1.0 µM (p = 0.0035), 2.0 µM (p = 
0.0003). 
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Figure 5. Photo-catalytic cycle for oxidation of NADH by complex 1 showing the 
production of NAD. radicals, involvement of oxygen, and reduction of cytochrome c. a) 
The reductive catalytic cycle under normoxia. b) Catalytic cycle under hypoxia in the 
presence of Fe3+-cyt c as electron acceptor. 
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1. Materials 
All solvents were of analytical grade. All buffer components were of biological grade 
and used as received. The cyclometalated ligand 3-phenylisoquinoline (3-pq), 
cisplatin, 5-aminolevulinic acid (5-ALA), oxidized cytochrome c (Cyt c) from beef 
heart, 5-(2,2-dimethyl-1,3-propoxycyclophosphoryl)-5-methyl-1-pyrroline N-oxide 
(CYPMPO), 5,5-dimethyl-1-pyrroline N-oxide (DMPO), 
2,2,6,6-tetramethylpiperidine (TEMP), β-nicotinamide adenine dinucleotide, reduced 
disodium salt (NADH), IrCl3
.3H2O, and human serum were from Sigma-Aldrich. 
5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), 
Mitotracker Red FM (MTR), Lysotracker green DND-26 (LTG), 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT),  
sulforhodamine B (SRB), 2′,7′-dichlorofluorescin diacetate (DCFH-DA) and cell 
apoptosis detection Annexin V/PI kit were bought from Life Technologies (USA). 
CellTitler-Glo® Cell Viability kit, CellTiter-Glo® 3D Cell Viability kit, ROS-Glo™ 
H2O2 kit and NAD/NADH-Glo™ kit were purchased from Promega (USA). Nucleus 
extraction kit, mitochondrial extraction kit and cytoplasm extraction kit were 
purchased from Thermo Scientific Pierce, Alexa Fluor 488 linked–Calreticulin 
antibody from Abcam, Cambridge (UK), and enzyme-linked immunosorbent test 
(ELISA) for high mobility group box 1 protein (HMGB1) from Cloud-Clone Corp 
(Wuhan, China). 
 
2. Instruments and methods   
2.1. X-ray crystallography  
Single crystals of 1 were grown by slow evaporation of solvent from toluene and 
acetonitrile solutions. A suitable crystal of compound [1]PF6·1.5(toluene) 
C47.5H39ClF6IrN4P was selected and mounted on a glass fibre with Fomblin oil and 
placed on a Rigaku Oxford Diffraction SuperNova diffractometer with a dual source 
(Cu at zero) equipped with an AtlasS2 CCD area detector. The crystal was kept at 
150(2) K during data collection. Using Olex21, the structure was solved with Solve 
structure solution program2 using Charge Flipping and refined with the ShelXL3 
refinement package using Least Squares minimization. X-ray crystallographic data for 
complex [1]PF6·(1.5 toluene) have been deposited in the CCDC under the accession 
number 1840366. 
 
2.2. Electrochemistry4 
Cyclic voltammogram (CV) experiments were carried out using a CH Instrument 
model 600D Electrochemical Analyzer/Workstation (Austin, TX). The 
electrochemical measurements were performed on complex 1 (1.0 mM) in acetonitrile 
solution containing tetrabutylammonium hexafluorophosphate (0.1 M) as supporting 
electrolyte. The solutions were degassed under nitrogen and cyclic voltammograms 
were scanned from -2.3 V to +2.3 V (three complete scans for each experiment). In a 
typical electrochemical experimental set up, the three-electrode system was used: a 
glassy carbon electrode as the working electrode, SCE as the reference electrode, and 
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platinum wire as the counter electrode. CV was performed at a scan rate of 100 mV/s. 
The excited state redox potentials were calculated from the ground state redox 
potentials and the emission maxima to aid evaluation of the photosensitization 
properties of complex 1. Excited state reduction potentials: E([M*]+/[M]0) = Ered + 
Eλem. Eλem = 1240/em.4 Throughout the manuscript, the American standard is 
followed to describe the electro-chemical parameters. 
 
2.3. NMR spectroscopy  
1H NMR spectra were acquired in 5 mm NMR tubes at 293 K or 310 K on either 
Bruker DPX 400 (1H = 400.03 MHz) or AVA 600 (1H = 600.13 MHz) spectrometers. 
1H NMR chemical shifts were internally referenced to CHD2OD (3.33 ppm) for 
d4-CD3OD. 2D 
1H–1H COSY NMR spectra were recorded at 293 K in d6-DMSO. All 
data processing was carried out using MestReC or TOPSPIN version 2.0 (Bruker UK 
Ltd.).  
 
2.4. Electrospray ionization mass spectrometry (ESI-MS) 
Electrospray ionization mass spectra were obtained by preparing the samples in 50% 
methanol and 50% H2O (v/v) or using NMR samples for infusion into the mass 
spectrometer (Bruker Esquire 2000). The mass spectra were recorded with a scan 
range of m/z 400–1000 for positive ions or negative ions.  
 
2.5. Elemental analysis 
CHN elemental analyses were carried out on a CE-440 elemental analyzer by 
Warwick Analytical (UK) Ltd.  
 
2.6. pH measurement 
pH values during photoredox catalysis in H2O at ca. 293 K were determined directly 
in 1-cm path-length quartz cuvettes (3 mL) during 460 nm light irradiation, using a 
Corning 240 pH meter equipped with a micro combination electrode calibrated with 
Aldrich buffer solutions of pH 4, 7 and 10.  
 
2.7. UV-vis spectroscopy 
A Cary 300 UV-vis spectrophotometer was used with 1-cm pathlength quartz cuvettes 
(3 mL) and a PTP1 Peltier temperature controller. Spectra were processed using UV 
Winlab software. Experiments were carried out at 293 K from 600 to 200 nm.  
 
2.8. Phosphorescence spectra  
Phosphorescence emission measurements were performed on a JASCO FP-6500 
spectrofluorometer. Complex 1 (10 M) in acetonitrile or phosphate buffer saline 
(PBS) was diluted from a stock solution in DMSO (1 mM). The complexes were 
excited at λex = 405 nm in a 1-cm quartz cuvette at 298 K. Experiments were 
performed in air.  
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2.9. Phosphorescence quantum yield and lifetimes 
Phosphorescence quantum yields were measured on a Fluorolog spectrofluorometer 
(Horiba Jobin Yvon) equipped with a 405 nm pulsed diode NanoLED light source. 
Ir(III) complexes were diluted from a stock solution in DMSO (1 mM) to achieve an 
absorbance = 0.1 at 405 nm in acetonitrile or PBS. The complexes were excited at λex 
= 405 nm in a 1-cm quartz cuvette at 298 K. Experiments were performed in air and 
emission spectra were corrected for the spectral sensitivity of the detection system by 
standard correction curves. Quantum yields in aerated acetonitrile were determined by 
comparison with the emission of [Ru(bpy)3]Cl2 in aerated water ( = 0.040)5. 
Phosphorescence lifetime measurements used the same equipment and measurement 
was stopped after gathering 1000 counts of excited state species. The raw data were 
analyzed with OriginPro 2016 software by using exponential function to obtain the 
phosphorescence lifetime. 
 
3. Synthesis of [Ir(ttpy)(pq)Cl]PF6 ([1]PF6) 
The polypyridyl ligand 4-p-tolyl-2,2:6,2-terpyridine (ttpy) was prepared as 
described by Wand and Hanan6. [Ir(ttpy)Cl3] was prepared based on the procedure 
reported by Porras et al4. 
A mixture of [Ir(ttpy)Cl3] (125 mg, 0.20 mmol) and excess 3-phenylisoquinoline 
(3-pq) (82 mg, 0.40 mmol) in glycol (10 mL) was stirred overnight at 453 K under 
nitrogen. The reaction mixture became a clear orange solution. After cooling to room 
temperature, the solution was poured into 50 mL saturated NH4PF6 solution to give an 
orange precipitate. The precipitate was isolated by filtration and washed with water 
and diethyl ether 3 times. The crude product was purified by column chromatography 
on neutral alumina oxide with methanol−dichloromethane (1:9 v/v) as the eluent. The 
solvent was removed under reduced pressure, and orange complex 1 was obtained.  
Yield: 45. ESI-MS [CH3OH, m/z]: 755.5 ([M-PF6]+) 。 Anal. calcd. for 
IrC37H27N4ClPF6: C, 49.36; H, 3.02; N, 6.22; found: C, 49.25; H, 3.09; N, 6.24. 
1H 
NMR (400 MHz, d6-(CD3)2SO)  10.66 (s, 1H), 9.28 (s, 2H), 9.00 (d, J = 9.6 Hz, 2H), 
8.99 (s, 1H), 8.45 (d, J = 8.2 Hz, 1H), 8.31 (d, J = 8.4 Hz, 1H), 8.28 (d, J = 8.2 Hz, 
2H), 8.23 (t, J = 8.0 Hz, 2H), 8.05 (t, J = 7.6 Hz, 1H), 8.00 (d, J = 7.6 Hz, 1H), 7.89 (t, 
J = 7.6 Hz, 1H), 7.81 (d, J = 5.4 Hz, 2H), 7.57 (d, J = 8.0 Hz, 2H), 7.48 (t, J = 6.4 Hz, 
2H), 6.96 (t, J = 7.6 Hz, 1H), 6.75 (t, J = 7.2 Hz, 1H), 6.08 (d, J = 7.6 Hz, 1H), 2.50 (s, 
3H). 13C NMR (101 MHz, DMSO)  158.39, 157.90, 155.79, 155.40, 152.47, 151.74, 
144.23, 141.83, 140.52, 139.72, 137.36, 134.07, 132.80, 130.62, 130.44, 129.82, 
129.61, 129.43, 128.91, 128.57, 128.49, 127.48, 126.43, 124.51, 124.34, 121.61, 
117.49, 21.45. 
Crystals of complex 1PF6 1.5(toluene) suitable for x-ray diffraction were grown by 
slow evaporation from a solution in toluene and acetonitrile (1:1 v/v).  
X-ray data have been deposited as CCDC 1840366. The asymmetric unit contains 
the complex, a PF6 counter ion, a toluene and a toluene on an inversion centre. The 
toluyl ring of the terpyridine was modeled as disordered over two positions related by 
S8 
 
a rotation about the bond to the terpyridine. The occupancy of the two components 
was linked to a free variable which refined to 55:45. There was a toluene solvent 
disordered over two closely related positions. The occupancy of the two components 
was linked to a free variable which refined to 71:29. The minor component was 
refined isotropically. There was another toluene disordered about the inversion centre. 
It was refined behind a PART -1 instruction at 50% occupancy. Several DFIX and 
SIMU restraints and an AFIX 66 constraint were used to give the disordered 
components reasonable bond lengths, angles and thermal parameters.  
 
4. Photocatalytic reactions of complex 1 with NADH  
4.1. 1H NMR spectra7 
NADH (3.5 mol equiv) was added to an NMR tube containing a 0.25 mM of complex 
1 in 50% CD3OD/49.5% D2O and 0.5% H2O at ambient temperature. 
1H NMR spectra 
of the resulting solutions were recorded at 310 K after 5 min or 24 h in the dark, or 
after 10 min of 463 nm light irradiation. 
 
4.2. UV-vis spectra 
Reactions between complex 1 and NADH at different ratios were monitored by 
UV-vis at 310 K in the dark or on irradiation with 463 nm light. Turnover number 
(TON) is defined as the number of moles of NADH that a mole of complex 1 can 
convert within 30 min. Turnover frequency (TOF) was calculated from the difference 
in NADH concentration after 30 min irradiation divided by the concentration of 
complex 1. The concentration of NADH was obtained using the extinction 
coefficient7 ε339 = 6220 M-1cm-1. 
 
4.3. Detection of H2O2 generation 
For the reaction of complex 1 (6 M) with NADH (240 M) in 0.5% DMSO/99.5% 
PBS (v/v) at 293 K in the dark or after irradiation, H2O2 was detected by Quantofix 
peroxide test sticks (Sigma). 
 
4.4. UV-vis spectra for reactions of 1, NADH and cyt c 
Reactions between complex 1 (0.6 M), NADH (48 M) and cyt c (11 M) under 
hypoxia were monitored by UV-vis in the dark or on irradiation with 463 nm light. 
PBS solution in a special cuvette (3 mL) was degassed by bubbling N2 for 15 min. 
Aliquots of stock solutions of cyt c (1 mM), NADH (10 mM) and complex 1 (1 mM) 
were added to the cuvette while continuously bubbling nitrogen into the PBS. The 
concentration of cyt c was obtained using extinction coefficients ε550 = 8000 M-1cm-1 
for oxidized cyt c, and ε550 = 28000 M-1cm-1 for reduced cyt c8. 
 
5. Electron paramagnetic resonance (EPR)9  
All EPR measurements were carried out at ambient temperature (ca. 293 K) on a 
Bruker Model A300 ESR spectrometer equipped with a Bruker ER 4122 SHQ 
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resonator, using 1.0 mm quartz tubes. Typical instrument settings were: modulation 
amplitude 2.0 G, microwave power 0.63 mW and X-band frequency ca. 9.88 GHz. 
Spectra were acquired at 20 dB microwave attenuation (non-saturating 2 mW 
microwave power) with modulation amplitude of 0.2 mT peak-to-peak, time constant 
of 1.28 ms, receiver gain 50–200; sweep time, 30 s and conversion time of 5.12 ms. 
The spin trap 2,2,6,6-tetramethylpiperidine (TEMP) was used to detect 1O2 in 
acetonitrile. 5,5-dimethyl-1-pyrroline-N-oxide (DMPO 10 mM) was used to trap 
radicals in PBS/methanol (50/50/, v/v). 5-(2,2-dimethyl-1,3-propoxycyclo-phosphory- 
l)-5-methyl-1-pyrroline N-oxide (CYPMPO, 1 mM) was used for NAD radicals in 
PBS/methanol (50/50/, v/v) solution containing complex 1 (50 M, methanol) and 
NADH (10 mM, PBS) under 463 nm irradiation. 2,2,6,6–Tetramethyl-piperidine 
(TEMP 10 mM) was used to trap singlet oxygen from complex 1 in methanol upon 
463 nm blue light excitation. 
6. Determination of singlet oxygen quantum yield  
An air-saturated acetonitrile solution, containing the tested compounds (A = 0.1 at 
irradiation wavelength), p-nitrosodimethyl aniline (RNO, 24 µM), imidazole (12 
mM). An air-saturated PBS buffer solution, containing the complex (A = 0.1 at 
irradiation wavelength), RNO (20 µM), histidine (10 mM) were irradiated in a 
luminescence quartz cuvette at 420 nm, recording the absorbance at various time 
intervals. Plots of A0–A at 440 nm in PBS or at 420 nm in acetonitrile (where A0 is the 
absorbance before irradiation) versus the irradiation time were prepared and the slope 
of the linear regression was calculated (Ssample). As a reference compound, 
phenalenone (ref (1O2) = 95 %)10 was used to obtain Sref Equation (1) was applied to 
calculate the singlet oxygen quantum yields (sample) for every sample: 
sample = ref *Ssample/Sref *Iref /Isample                                                     (1) 
 I=I0*(1 - 10
-A
)                                                   (2) 
I (absorbance correction factor) was obtained from Equation (2), where I0 is the light 
intensity of the irradiation source in the irradiation interval and A is the absorbance 
of the sample. 
 
7. Computational details  
7.1 Density functionals  
All calculations were performed using a local version of the Gaussian16 program 
suite11. All density functional computations were carried out with the 
dispersion-corrected B3LYP-D3BJ functional. The Becke-Johnson damped 
D3 dispersion correction was added given the NADH-1 interaction complexes studied 
(vide infra). This functional was also calibrated against other functionals with 
differing amounts of exact exchange for other properties such as complex 1 
geometries, isomeric energetics, and excitation energies (relative to experimental 
band maxima). It performed consistently across these, so was used for all calculations 
discussed below. The Def2-TZVPP basis was coupled with a Stuttgart-Dresden 
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(SDD) effective core potential for the iridium (60 core electrons). This basis is 
property optimized and has previously been shown to give an excellent 
cost-to-accuracy balance for related properties to those under study in this work12. 
The SMD solvent model was chosen as this can provide robust redox potentials as 
discussed below. Minima were confirmed by noting a positive definite geometrical 
Hessian matrix obtained by analytical differentiation.  
 
7.2 Ground and excited state geometries.  
Two isomers of 1 are possible, each distinguished by the phenylisoquinoline N or C 
trans to the Cl. The C-Cl trans isomer is 33.5 kJ mol-1 lower in energy so was used 
for all subsequent theoretical investigations. This configuration is observed in the 
x-ray crystal structure (Fig. 1b). Table S6 shows selected geometrical parameters for 
each of the ground state singlet and excited triplet geometries. Excited electronic 
states were obtained via time-dependent (TD) linear response calculations for the first 
thirty singlet and triplet states. Table S3 shows the excitation energies, oscillator 
strengths, and characterization for the lowest excited states. Fig. S2 shows a simulated 
one-photon absorption spectrum of 1 in vacuum and various solvents, while Fig. S6 
shows the canonical frontier orbitals.  
 
7.3. Two-photon absorption cross section  
The two-photon absorption cross section was calculated using the non-resonant 
3-state sum-over-states model of Ågren et al.,13 using the linear response 
ground-to-excited transition moments, and the approximate excited-to-excited 
transition moments obtained from the a posteriori Tamm–Dancoff approximation 
(ATDA)14.  
The two-photon absorption spectra of complex 1 were determined over a broad 
spectral region by the typical two-photon induced luminescence (TPL) method relative 
to Rhodamine B in methanol as the standard devised by Webb and Xu15. The 
two-photon luminescence data were acquired using an OpoletteTM 355II (pulse width ≤ 
100 fs, 80 MHz repetition rate, tuning range 700-800 nm, Spectra Physics Inc., USA). 
Two-photon luminescence measurements were performed in fluorometric quartz 
cuvettes. The experimental luminescence excitation and detection condition were 
conducted with negligible reabsorption processes, which can affect TPA 
measurements. The quadratic dependence of two-photon induced luminescence 
intensity on the excitation power was verified at an excitation wavelength of 760 nm. 
The two-photon absorption cross section of the probes was calculated at each 
wavelength according to equation (3):  
1122
2211
12 nIC
nIC

                    (3)                                            
where I is the integrated luminescence intensity, C is the concentration, n is the 
refractive index, and  is the quantum yield. Subscript ‘1’ stands for reference samples, 
and ‘2’ stands for samples. 
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7.4. Redox and photo-redox potentials  
The calculated redox and photo-redox potentials of 1 were obtained from the Gibbs 
energies of the singlet and triplet states relative to the optimized ionized and attached 
electronic states.16 Standard statistical thermodynamics models were used for the 
entropic contributions to the free energies. Absolute standard potentials were obtained 
from the solvated free energies at 293 K via:   
                 (4) 
where n is the number of electrons transferred (n=1 here), F is the Faraday constant, 
and Gred(sol) is the Gibbs energy for the solvated reduction half-reaction (obtained 
directly via the appropriate Born-Haber type cycle), with the last term accounting for 
the Gibbs free electron correction at 293 K. The particular protocol has previously 
been used successfully for calculating challenging aqueous copper complex redox 
potentials17, and the SMD solvent model in particular has been shown to be robust 
and provide accurate such properties from DFT calculations. Conversions from 
absolute potentials to those versus the SCE were made by first correcting to versus 
SHE via the optimized SMD model shift of +4.28V18, followed by a standard 
correction of +0.241V from SHE to SCE.  
 
7.5. Interaction between complex 1 and NADH 
DFT calculations provided two structures for the closed interaction complex between 
1 and NADH. Several of these were optimized starting at four possible ‘clamped’ 
sites with the NADH around each of the conjugated hetero-aromatic units. The 
structure in Fig. 3d shows the triplet 1-NADH interaction complex around the 
phenylisoquinoline (with maximum hole amplitude), and one of two symmetric triplet 
1-NADH interaction complexes around the terpyridine (with maximum particle 
amplitude). These geometries (which are stable minima in both singlet and triplet 
states) are likely to facilitate the photo-redox electron transfer processes. 
 
7.6. Photocatalytic reduction of Fe3+-cyt c by complex 1 and NADH. 
Photocatalytic reduction of oxidized Fe3+-cyt c (11.2 M) by 1 (0.6 M) in the 
presence of NADH (50 M) was studied by UV-vis spectroscopy at 310 K in the dark 
or on irradiation with 463 nm light. The PBS solution was degassed by sonication for 
10 min followed by purging with N2 for 30 min. Stock solutions of Fe
3+-cyt c (10 mM 
in PBS), NADH (100 mM in PBS) and complex 1 (1 mM in DMSO) were added 
under a N2 atmosphere. TON is defined as the number of moles of Fe
3+-cyt c that a 
mole of 1 can convert within 30 min. TOF was calculated from the difference in 
Fe3+-cyt c concentration after 30 min divided by the concentration of complex 1. The 
concentration of Fe3+-cyt c was determined using the extinction coefficient ε550 = 29.5 
mM-1cm-1; (reduced form), ε550 = 8.4 mM-1cm-1 (oxidized form). 
 
8. Cell culture and cell assays 
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8.1. Cell culture 
A549 human lung carcinoma and normal human lung fibroblast cell line MRC-5 were 
obtained from the European Collection of Cell Cultures (ECACC). Human lung 
cancer cell line NCI-H460, human cervix cancer cell line HeLa and human liver 
cancer cell line Hep G2 were obtained from the American Type Culture Collection 
(ATCC, Manassas, VA). Human gastric cancer cells SGC-7901 and the human 
hepatocyte cell line LO2 were purchased from the Experimental Animal Center, Sun 
Yat-sen University (Guangzhou, China). A549, MRC-5 and LO2 cell lines were 
grown in Roswell Park Memorial Institute medium (RPMI-1640) supplemented with 
10% fetal calf serum, 100 μg/mL streptomycin and 100 U/mL penicillin. NCI-H460, 
HeLa, Hep G2 and SGC-7901 cell lines were grown in Dulbecco's Modified Eagle 
Medium (DMEM) supplemented with 10% fetal calf serum, 100 μg/mL streptomycin 
and 100 U/mL penicillin. These cells were grown as adherent monolayers at 310 K in 
a 5% CO2 humidified atmosphere and passaged at 70-80% confluence. 
 
8.2. Dark- and photo-cytotoxicity assays  
For adherent cells, 5000 cells were seeded per well in 96-well plates (Costar) at 310 K 
in a 5% CO2/95% air incubator (Thermo) for 24 h. The cells for hypoxic treatment 
were then transferred to an hypoxic incubator, placed in a biological safety cabinet 
within a glove box (Lonyue, Shanghai) at 310 K, 1% O2, 5% CO2 and 94% N2 for 
another 24 h allowing the cells to adapt to hypoxic conditions. Stock solutions of 
complex 1 was firstly prepared in 5% DMSO (v/v) and a mixture of 0.9% sterilized 
saline and cell culture medium (1:1 v/v) following serial dilutions with cell culture 
medium. A stock solution of cisplatin (2 mM) was freshly prepared in sterilized saline, 
and 5-aminolevulinic acid hydrochloride (5-ALA, 100 mM) was freshly prepared in 
cell culture medium. The drug exposure period was 2 h for complex 1, 4 h for 5-ALA 
and 48 h for cisplatin. After this, the supernatants of cells treated complex 1 and 
5-ALA were removed by suction and replaced with fresh medium. For dark treatment 
after drug exposure, the medium was replaced with drug-free cell culture medium. For 
light treatment, the cells were then irradiated in phenol-red-free cell culture medium 
under normoxia (20% O2, 465 nm, light dose 8.9 J/cm
2) at the University of Warwick 
or hypoxia (1% O2, 450 nm, light dose 10.0 J/cm
2) at Sun Yat-sen University. 
Cisplatin-treated cells were irradiated after 4 h incubation without replacing the 
medium. After treatment, the cells were left to recover for 46 h in the incubator under 
20% O2 or 1% O2 at 310 K. Finally, the photo-cytotoxicity under normoxia was 
determined by the sulforhodamine B (SRB) assay19 on a GloMax-Multi Microplate 
Multimode Reader at the University of Warwick. The photo-cytotoxicity under 
hypoxia was evaluated using the MTT assay20 on a microplate spectrophotometer 
(Biorad). All the IC50 values (concentrations which caused 50% of cell death) were 
determined as duplicates of triplicates in two independent sets of experiments and 
their standard deviations were calculated. 
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For 3D spheroid models, A549 lung multicellular spheroids (MCSs) were cultured 
using the liquid overlay method. A549 cells in exponential growth phase were 
dissociated by trypsin/EDTA solution to gain single-cell suspensions. Aliquots of 
3000 A549 cells were transferred to cell-repellent surface U-bottom 96 well plates 
(650970, Greiner bio-one, Germany) with 200 μL of cell culture medium. These cells 
were left in an incubator with 5% CO2 in air at 310 K and gradually formed A549 
MCS ca. 800 μm in diameter after 1 week of incubation. After 6 h incubation with 
various doses of complex 1，cisplatin or 5-ALA, the spheroids were then either left in 
the dark or received light irradiation. For light treatment, the MCS were irradiated by 
760 nm two photon light (10 s/section, section interval = 3 μm, light dose = 12 J cm-2) 
using a pulsed laser from confocal microscopy (LSM 710, Carl Zeiss, Göttingen, 
Germany). After 66 h incubation at 20% O2, 310 K, the photo-cytotoxicity was 
determined by CellTitler-Glo® 3D Cell Viability kit (Promega). The results were 
processed as duplicates of triplicates in two independent sets of experiments and their 
standard deviations were calculated. 
 
8.3. Cellular localization assays 
A549 cells were seeded in a glass-bottom dish (35 mm dish with 20 mm bottom well 
(Costar) at 310 K in a 5% CO2/95% air incubator. The cells were incubated with 
complex 1 (5 M) at 310 K for 1 h and further stained with 100 nM MTR and LTG. 
Cell imaging was visualized by confocal microscopy (LSM 710, Carl Zeiss, 
Göttingen, Germany) with a 63 oil-immersion objective lens immediately. 
Excitation/emission: 1 one-photon 405/562 nm and two-photon 760/562 nm, LTG 
488/520 nm, MTR 633/660 nm. 
 
8.4. ICP-MS assays22 
Exponentially growing A549 cells were harvested, and the resulting single-cell 
suspension was plated into 100 mm tissue culture plates (Costar). After 24 h at 310 K 
5% CO2/95% air incubator, the cells were treated with 5 M complex 1 for 2 h at 310 
K in full RPMI-1640 cell culture medium. The cells were rinsed with PBS, detached 
with trypsin, counted and divided into three portions. Using the first portion, the 
nuclei were extracted using a nucleus extraction kit (Pierce, Thermo) following the 
manufacturer’s protocol; for the second portion, the cytoplasm was extracted using a 
cytoplasm extraction kit (Pierce, Thermo); and for the third portion, the mitochondria 
were extracted using a mitochondrial extraction kit (Pierce, Thermo). The cell 
fractions were digested with 60% HNO3 at ambient temperature for one day. Each 
sample was diluted with MilliQ H2O to achieve 2% HNO3 sample solutions. The 
iridium content was measured using inductively coupled plasma mass spectrometry. 
The Ir concentrations in different cell components were determined as duplicates of 
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triplicates, as part of two independent experiments, and the standard deviations were 
calculated. Statistical significances were determined using Welch’s t-test. 
 
8.5. Phosphorescence lifetime imaging microscopy (PLIM)23 
A549 cells were seeded in a 35 mm glass bottom dish (Costar) and treated with 
complex 1 (5 M) for 1 h followed by washing with fresh cell culture medium. PLIM 
was conducted by using a TI: SAPPHIRE pulsed laser (Coherent Chameleon) on a 
confocal microscope (LSM 710, Carl Zeiss, Göttingen, Germany) combined with a 
time-correlated single photon counting system (Becher & Hickl). The data were 
processed using SPCImage software (Becker & Hickl). The two-photon excitation 
wavelength for complex 1 was 760 nm. Emission filter: 565  20 nm. 
 
8.6. Intracellular ROS measurement  
The production of intracellular ROS was detected by DCFH-DA. A549 cells were 
seeded in a 35 mm glass bottom dish (Costar) for 24 h. For hypoxic treatment, the 
cells were then transferred to an hypoxic incubator located in a glove box (Lonyue, 
Shanghai) at 310 K in a 5% CO2/1% O2 for another 24 h incubation allowing the cells 
to adapt to hypoxic conditions. The cells were treated with 2 IC50 of 1 (normoxia 3 
M, hypoxia 5 M) for 2 h. Then the cells received dark- or light-treatment as 
mentioned for the dark- and photo-cytotoxicity assays. Immediately after treatment, 
the cells were stained with DCFH-DA (10 μM) in serum-free cell culture medium in 
the incubator for 30 min at 310 K in the dark, and subsequently washed with 
serum-free cell culture medium. The ROS fluorescence was imaged by an inverted 
fluorescence microscope (Zeiss Axio Observer D1, Germany) with ex/em: 488/520 
nm. 
 
8.7. Two-photon induced ROS generation in A549 multicellular spheroids 
(MCSs)20 
ROS generation in A549 MCS was verified by using DCFH-DA. A549 MCS were 
incubated with complex 1 (2 M) followed by careful washing with PBS and 
subjected to two-photon irradiation by laser scanning confocal microscopy LSM 710 
(760 nm, 10 s/section, section interval = 3 μm). DCFH-DA (10 M) was added and 
incubated with MCS at 310 K for 1 h and then subjected to z-axis stack imaging. 
Excitation/emission: 1 two-photon 760/562 nm, DCF 488/520 nm. 
 
8.8. Intracellular NADH concentration 
1×104 cells were seeded per well in 96-well plates (Costar) at 310 K in a 5% CO2/95% 
air incubator (Thermo) for 24 h. The cells were treated with complex 1 for 2 h. After 
this, supernatants were removed by suction and each well was washed with 1 PBS. 
For light treatment, the cells were then irradiated in phenol red-free cell culture 
medium under normoxia (20% O2, 465 nm, light dose 8.9 J/cm
2). The cells were 
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allowed to recover for a further 6 h in an incubator at 310 K. The NAD/NADH-Glo™ 
kit (Promega) was used to measure the cellular NADH concentration according to the 
manufacturer’s instructions. The luminescence was recorded using a microplate 
reader (GloMax-Multi Microplate Multimode Reader). The cellular NADH 
concentrations were determined as duplicates of triplicates, as part of two independent 
experiments, and the standard deviations were calculated. Statistical significances 
were determined using Welch’s t-test. 
 
8.9. Intracellular ATP concentration 
1×104 cells were seeded per well in 96-well plates (Costar) at 310 K in a 5% CO2/95% 
air incubator (Thermo) for 24 h. The cells were treated with complex 1 (2 light IC50, 
normoxia 3 M, hypoxia 5 M) for 2 h. After this, supernatants were removed by 
suction and each well was washed with 1 PBS. For light treatment, the cells were 
then irradiated in phenol red-free cell culture medium under normoxia (20% O2, 465 
nm, light dose 8.9 J/cm2). The cells were allowed to recover for a further 6 h in an 
incubator at 310 K. Then CellTiter-Glo reagent (Promega) was added to each well, 
and then the plate was shaken for 2 min, and incubated for 10 min at ambient 
temperature. The luminescence was recorded using a microplate reader 
(GloMax-Multi Microplate Multimode Reader). The cellular ATP concentrations were 
determined as duplicates of triplicates, as part of two independent experiments, and 
the standard deviations were calculated. Statistical significances were determined 
using Welch’s t-test.  
 
8.10. Intracellular H2O2 concentration20  
1×104 cells were seeded per well in 96-well plates (Costar) at 310 K in a 5% CO2/95% 
air incubator (Thermo) for 24 h. The cells were treated with complex 1 only, or 
co-incubated with complex 1 and 5 mM N-acetyl-L-cysteine (NAC) for 2 h. After this, 
supernatants were removed by suction and each well was washed twice with 1 PBS. 
For light treatment, the cells were then irradiated in phenol-red-free cell culture 
medium under normoxia (20% O2, 465 nm, light dose 8.9 J/cm
2). For dark treatment, 
after drug exposure, the cells were washed and treated with fresh cell culture medium. 
After irradiation, ROS-Glo™ H2O2 kit (Promega) was used to measure the 
intracellular H2O2 concentration according to the manufacturer’s instructions. The 
luminescence was recorded using a microplate reader (GloMax-Multi Microplate 
Multimode Reader). The cellular H2O2 concentrations were determined as duplicates 
of triplicates, as part of two independent experiments, and the standard deviations 
were calculated. Statistical significances were determined using Welch’s unpaired 
t-test at the 95% confidence level. 
 
8.11. Formazan formation assay 
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Approximately 1×104 cells/well were seeded in 96-well plates, followed by 
incubation at 310 K 5% CO2/95% air for 24 h. The cells were treated with serially 
diluted solutions of complex 1 for 2 h. The supernatants were removed by suction and 
each well was washed with PBS. For light treatment, the cells were irradiated (20% 
O2, 465 nm, light dose 8.9 J/cm
2) in phenol red-free cell culture medium, and the cells 
were than left to recover in the incubator for another 46 h. For dark treatment, the 
cells were placed in fresh cell culture medium and kept in an incubator for another 46 
h. Finally, 20 μL of MTT solution (5 mg/mL in 1× PBS) was added to each well, 
followed by incubation for 4 h at 310 K in the incubator. The cells were then imaged 
by an inverted fluorescence microscope (Zeiss, Germany).  
 
8.12. Mitochondrial membrane potentials (ΔΨm) 
The mitochondrial membrane potential was determined by using JC-1 dye. A549 cells 
were seeded in a 35 mm glass bottom dish (Costar) for 24 h. For hypoxic treatment, 
the cells were then transferred to a hypoxic incubator located in a glove box (Lonyue, 
Shanghai) at 310 K in a 5% CO2/1% O2 for another 24 h incubation allowing the cells 
to adapt to hypoxic conditions. The cells were treated with 2 IC50 of 1 (normoxia 3 
M, hypoxia 5 M) for 2 h. Then the cells received dark- or light-treatment as 
mentioned for the dark- and photo-cytotoxicity assays. Following this, cells were 
stained with JC-1 (5 μg/mL) at 310 K for 0.5 h and washed with fresh cell culture 
medium. The cells were imaged by an inverted fluorescence microscope (Zeiss Axio 
Observer D1, Germany). Excitation/emission: green 488/530 nm and red 488/590 nm. 
 
8.13. Annexin V/PI assay 
Cell apoptosis was detected by Annexin V/PI dual staining. A549 cells were seeded in 
a 35 mm glass-bottom dish (Costar) for 24 h. For hypoxic treatment, the cells were 
then transferred to an hypoxic incubator located in a glove box (Lonyue, Shanghai) at 
310 K in a 5% CO2/1% O2 for another 24 h incubation allowing the cells to adapt to 
hypoxic conditions. The cells were treated with 2 IC50 of 1 (normoxia 3 M, 
hypoxia 5 M) for 2 h. Then the cells received dark- or light-treatment as appropriate 
for dark- and photo-cytotoxicity assays, and were allowed to recover for a further 6 h 
in the incubator at 310 K. For dark treatment, cells, after drug exposure, were washed 
and incubated in drug-free cell culture medium at 310 K for 6 h. The cells were 
subsequently stained with 5 μL annexin V-FITC and 10 μL PI stock solution in the 
incubator at 310 K for 30 min in the dark. The fluorescence images were obtained on 
an inverted fluorescence microscope (Zeiss Axio Observer D1, Germany). 
Excitation/emission: Annexin V 488/530 nm and PI 530/620. 
 
8.14. Calreticulin Immunofluorescence assay 
Immunofluorescence assays for calreticulin were carried out using an Alexa Fluor 488 
linked–calreticulin antibody to detect any immunogenic-apoptotic cell death induced 
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by complex 1 upon light irradiation. A549 cells were treated with complex 1 (3 M) 
or cisplatin (200 M) or oxaliplatin (200 M) at 310 K for 2 h, washed and irradiated 
with 450 nm light (10 J/cm2) followed by recovery for 12 h. Then the cells were 
stained with Alexa Fluor 488 linked–calreticulin antibody (Abcam, Cambridge, UK) 
without permeabilization and imaged by confocal microscopy (LSM 710, Carl Zeiss, 
Göttingen, Germany). Excitation/emission: 488/520 nm. 
  
8.15. HMGB1 ELISA assay 
An enzyme-linked immunosorbent assay (ELISA) of high mobility group box 1 
protein (HMGB1) was performed to check the possibility of immunogenic-apoptotic 
cell death induced by complex 1 upon light irradiation. A549 cancer cells were 
incubated with complex 1 (3 M), cisplatin (200 M) or oxaliplatin (200 M) at 310 
K for 2 h, washed with PBS and irradiated with 450 nm light (10 J/cm2) followed by 
recovery for 12 h. The amount of HMGB1 released from the cells was detected by a 
HMGB1 ELISA kit according to the manufacturer's instructions (Cloud-clone, 
Wuhan, China). Statistics were calculated using the two-tailed t-test with unequal 
variances (Welch’s unpaired t-test). *p < 0.05, **p < 0.01 ***p < 0.001 
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Supplementary Table 1. X-ray crystal data and structure refinement for [1]PF6 
1.5(toluene) 
Identification code sb10  
Empirical formula C47.5H39ClF6IrN4P 
Formula weight 1038.44 
Temperature/K 150(2) 
Crystal system triclinic 
Space group P-1 
a/Å 12.4658(2) 
b/Å 13.2099(2) 
c/Å 14.7786(2) 
α/° 82.1100(10) 
β/° 73.2830(10) 
γ/° 64.049(2) 
Volume/Å3 2095.57(6) 
Z 2 
ρcalcg/cm3 1.646 
μ/mm-1 3.354 
F(000) 1030.0 
Crystal size/mm3 0.3 × 0.06 × 0.04 
Radiation MoKα (λ = 0.71073) 
2θ range for data collection/° 4.108 to 60.826 
Index ranges -17 ≤ h ≤ 17, -18 ≤ k ≤ 18, -20 ≤ l ≤ 20 
Reflections collected 101409 
Independent reflections 11731 [Rint = 0.0663, Rsigma = 0.0363] 
Data/restraints/parameters 11731/52/599 
Goodness-of-fit on F2 1.037 
Final R indexes [I>=2σ (I)] R1 = 0.0332, wR2 = 0.0763 
Final R indexes [all data] R1 = 0.0432, wR2 = 0.0823 
Largest diff. peak/hole / e Å-3 1.70/-1.36 
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Supplementary Table 2. Selected x-ray crystallographic bond lengths (Å) and angles 
(°) for [1]PF6·1.5(toluene). 
Bond lengths (Å) 
Ir(1)-N(33) 2.051(2) 
Ir(1)-N(17) 2.047(2) 
Ir(1)-N(1) 2.074(3) 
Ir(1)-N(23) 1.949(3) 
Ir(1)-N(33) 2.051(2) 
Ir(1)-Cl(1) 2.4643(8) 
Bond angles (°) 
C(16)-Ir(1)-N(33) 91.90(10) 
C(16)-Ir(1)-N(17) 91.36(10) 
C(16)-Ir(1)-N(1) 80.33(9) 
C(16)-Ir(1)-Cl(1) 175.09(6) 
N(33)-Ir(1)-N(1) 101.52(10) 
N(33)-Ir(1)-Cl(1) 87.38(8) 
N(17)-Ir(1)-N(33) 160.47(11) 
N(17)-Ir(1)-N(1) 98.01(10) 
N(17)-Ir(1)-Cl(1) 90.93(8) 
N(1)-Ir(1)-Cl(1) 95.05(8) 
N(23)-Ir(1)-C(16) 94.15(10) 
N(23)-Ir(1)-N(33) 80.24(10) 
N(23)-Ir(1)-N(17) 80.32(10) 
N(23)-Ir(1)-N(1) 174.22(10) 
N(23)-Ir(1)-Cl(1) 90.52(8) 
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Supplementary Table 3. Selected singlet-singlet (S0–Sn) and singlet-triplet (S0–Tm) 
excitations calculated with TD-DFT (in CH2Cl2): vertical excitation energies (nm 
[eV]), response eigenvector coefficients (|c| > 0.18), orbitals involved in the 
transitions, and oscillator strengths (f) for complex 1 (with f > 0.05), for states up to 
4.0 eV. 
States Transitions 
Singlet excited states Sn 
n = 1 (LLCT/MLCT) 
525.4 [2.36] (f = 0.0089) 
HL (0.68) 
n = 3 (LLCT/MLCT) 
424.8 [2.92] (f = 0.2298) 
H-1L (0.62) 
HL+1 (0.27) 
n = 9 (LLCT/MLCT) 
353.4 [3.51] (f = 0.2572) 
H-4L (0.68) 
n = 11 (LLCT/MLCT) 
343.2 [3.61] (f = 0.1480) 
HL+3 (0.65) 
n = 18 (LLCT/MLCT) 
322.4 [3.85] (f = 0.0885) 
H-8L (0.50) 
H-5L (0.40) 
H-4L+1 (0.19) 
Exp. em. maxb (nm) 562 
Calc. em. maxc (nm) 567 
Triplet excited states Tm 
m = 1 (LLCT/MLCT) 
547.9 [2.26] 
HL (0.65) 
H-2L (0.23) 
m = 2 (LLCT/MLCT) 
519.0 [2.39] 
H-1L (0.64) 
m = 3 (LLCT/MLCT) 
505.9 [2.45] 
HL+2 (0.47) 
H-3L+2 (0.36) 
a H = HOMO, L = LUMO b recorded at ambient temperature in CH2Cl2 
c calculated as the 
energy difference between the DFT optimized ground state and lowest triplet stat 
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Supplementary Table 4. Photophysical properties of complex 1 in various solvents 
at ambient temperature (293 K). 
 
  
Solvent 
Absorption  
/nm 
(log ε) 
Emission 
/nma 
Emission 
quantum     
yieldb /% 
Emission      
lifetime/ns 
air      N2 
CH2Cl2 279 (4.89), 320 (4.66),  
328 (4.62), 352 (4.20),  
410 (4.32)  
562 17.84 n.d. n.d. 
CH3CN 277 (4.89), 321 (4.63),  
330 (4.54), 348 (4.23),  
375 (4.26)  
566 9.74 743.7 1390.3 
CH3OH 277 (4.97), 319 (4.73),  
327 (4.67), 350 (4.30),  
375 (4.33)  
560 11.92 n.d. n.d. 
H2O 272 (4.78), 320 (4.50),  
324 (4.46), 350 (4.30),  
405 (3.95)  
565 3.89 330.8  
(171.6)c 
382.3 
a Excitation wavelength 405 nm. b In aerobic acetonitrile. c In the presence of NADH. 
 
 
 
Supplementary Table 5. Electrochemical properties of complex 1 and related 
complexes in acetonitrile. 
 
Complex 
Ground state a /V Excited State /V 
E1/2 ([M]+/[M]) 
 
I: E1/2 E1/2([M]+/[M*])
b E1/2([M*]/[M]-)
b 
Complex 1 +1.71 -0.97 -0.48 +1.22 
[Ir(ppy)2(bpy)]
+c +1.21 −1.51 −0.85 +0.68 
fac-[Ir(ppy)3]
 c +0.77 −2.19 −1.73 +0.31 
[Ir(dF(CF3)ppy)2(dtbbpy)]
+c  +1.69 −1.37 −0.89 +1.21 
[Ru(bpy)3]
2+ c  +1.29 −1.33 −0.81 +0.77 
[Ru(phen)3]
2+ c +1.26 −1.36 −0.87 +0.82 
a All measurements in 0.1 M NBu4PF6-CH3CN, errors in potentials 0.02 V; T = 293 K scan 
rate = 100 mVs-1 under N2. Potentials in V vs SCE. 
b Excited state reduction potentials: 
E([M*]/[M]-) = E1/2 + Eλem. Hppy: 2-phenylpyridine; fac, facial; bpy, 2,2′-bipyridine; 
dF(CF3)ppy, 2-(2,4-difluorophenyl)-5-trifluoro-methylpyridine; dtbbpy, 4,4′-di-tert-butyl- 
2,2′-dipyridyl; phen, 1,10-phenanthroline; E1/2, half-wave potential (reduction of metal 
complex), based on peak current I; M, metal complex or photoredox catalyst; * refers 
to excited state. c Values from Chem. Rev. 2013, 113, 5322-5363. 
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Supplementary Table 7. Computed redox potentials for complex 1  
 
Redox SMD H2O vs SCE / V 
[M]+/[M]0 -1.362 
[M*]+/[M]0 +0.657 
[M]+/[M]2+ +1.053 
[M*]+/[M]2+ -0.967 
 
Supplementary Table 6. DFT optimized parameters for the singlet ground state and 
first triplet excited state of 1 (atom numbering shown in Supplementary Fig. 11). 
 
  singlet ground state first triplet excited state 
Bond lengths (Å) 
Ir – C6 2.030 1.986 
Ir – N3 2.051 2.063 
Ir – N4 1.957 1.962 
Ir – N5 2.051 2.050 
Ir – N58 2.086 2.103 
Ir – Cl 2.471 2.430 
Bond angles (°) 
Cl – Ir – N3 89.42 87.12 
Cl – Ir – N4 87.78 89.05 
Cl – Ir – N5 89.36 91.44 
Cl – Ir – N58 94.55 93.76 
N3 – Ir – N4 80.42 80.06 
N3 – Ir – N58 99.55 100.95 
N3 – Ir – C6 91.44 89.30 
N4 – Ir – N5 80.42 80.67 
N4 – Ir – C6 97.50 96.46 
N5 – Ir – N58 99.60 98.36 
N5 – Ir – C6 91.53 93.98 
N58 – Ir – C6 80.17 80.81 
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Supplementary Table 8. Photocatalytic oxidation of NADH by complex 1 in PBS 
buffer under various conditions. 
 
Entry Complex 1 NADH NADH/1 Light TON TOF  
 µM µM  nm  h-1  
1 0 120 - dark 0 n.a.  
2 0 120 - 463 0 n.a.  
3 0.6 120 200 dark 0 n.a.  
4 3 120 40 dark 0 n.a.  
5 6 120 20 dark 0 n.a.  
6 0 120 - 463 0 n.a.  
7 0.6 120 200 463 20.1 40.2  
8 3 120 40 463 16.8 33.6  
9 6 120 20 463 11.8 23.6  
10 6 240 40 463 22.3 44.6  
11 6 360 60 463 26.7 53.4  
12 6 480 80 463 32.5 65.1  
13 10 480 48 463 50.2 100.4  
15 10 480 48 517 18.3 36.6  
16 10 480 48 593 1.4 2.8  
n.a.= not available. 
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Supplementary Table 9. Dark- and photo-toxicity towards cancer and normal cell lines 
(IC50/M). 
 
Treatment 
Normoxia Hypoxia 
Dark Light PI Dark Light PI 
Cell line NCI-H460 
1a 16.60.9 1.00.1 16.6 31.63.8 8.71.0 3.6 
Cisplatinb 8.70.3 10.40.9 n.a. 30.80.8 27.00.5 n.a. 
5-ALAc 10000 10000 n.a. 10000 10000 n.a. 
Cell line HeLa 
1a 35.41.9 1.90.3 18.6 43.63.3 5.20.4 8.3 
Cisplatinb 7.10.8 6.00.5 n.a. 15.90.8 16.70.7 n.a. 
5-ALAc 10000 2510280 >4.0 10000 10000 n.a. 
Cell line SGC7901 
1a 19.91.2 1.10.1 18.1 23.61.5 5.80.4 4.0 
Cisplatinb 10.20.7 9.70.9 n.a. 26.62.5 23.11.9 n.a. 
5-ALAc 10000 2800300 >3.5 10000 10000 n.a. 
Cell line Hep G2 
1a 50 1.90.1 25 50 3.50.3 14 
Cisplatinb 9.30.8 10.41.3 n.a. 28.51.4 30.12.4 n.a. 
5-ALAc 10000 10000 n.a. 10000 10000 n.a. 
Cell line A549 
1a 43.62.5 1.60.1 27.2 42.52.3 2.30.3 18.5 
1 + NaN3a 47.33.7 3.50.4 12.7 44.82.3 2.50.2 17.9 
1 + D-mannitola 44.51.6 5.00.6 9.5 48.31.9 2.20.3 22.0 
1+NaN3+D-mannitola 43.51.8 7.30.8 5.9 46.13.2 2.60.1 17.8 
Cisplatinb 8.31.2 8.60.9 n.a. 25.32.6 23.22.0 n.a. 
5-ALAc 10000 10000 n.a. 10000 10000 n.a. 
Cell line A549 spheroids  
Treatment 
Normoxia  
Dark Light PI    
1d 12.61.9 1.31.9 9.7    
Cisplatind 61.52.8 64.22.8 n.a.    
5-ALAd 10000 10000 n.a.    
Cell line MRC-5 LO2 
Treatment 
          Normoxia Normoxia 
Darka Lightb PI Darka Lightb PI 
1a 43.24.1 2.80.2 15.4 31.92.0 2.80.2 11.4 
Cisplatinb 12.72.2 11.21.9 n.a. 13.40.9 13.21.5 n.a. 
5-ALAc 10000 2819390 3.5 10000 3019420 3.3 
aCells were treated with complex 1 for 2 h, replaced with fresh medium and keep in the dark 
or received irradiation following 46 h incubation under normoxia or hypoxia at 310 K. bCells 
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were treated with cisplatin kept in the dark or received irradiation after 4h incubation without 
replacing the medium and following 44 h under normoxia or hypoxia at 310 K. cCells were 
treated with 5-ALA for 4 h, replaced with fresh medium and keep in the dark or received 
irradiation following 44 h incubation under normoxia or hypoxia at 310 K. Light dose: under 
normoxia 465 nm, 8.9 J/cm2, under hypoxia 450 nm, 10.0 J/cm2. d Spheroids were incubated 
with compounds for 6 h without replacing the medium, followed by irradiation with a pulsed 
laser (760 nm, 10 s/section, section interval = 3 μm, light dose = 12 J/cm2) by a two-photon 
confocal microscope, and a further 66 h incubation under normoxia at 310 K. PI = dark IC50 / 
light IC50 ; n.a.: not available. All the experiments were performed as duplicates of triplicates 
(n=6 biologically independent experiments). The error bars were calculated as the S.D. from 
the mean. 
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Supplementary Figure 1. UV–vis spectra of complex 1 (10 M) in various solvents. 
These experiments were repeated three times independently with similar results. 
 
 
 
 
 
 
Supplementary Figure 2. Simulated electronic absorption spectrum for 1 in various 
media obtained with TD-DFT coupled with the SMD solvent model convoluted over 
30 singlet electronic states. 
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Supplementary Figure 3. Phosphorescence spectra of complex 1 (10 M) in various 
solvents, excitation wavelength: 405 nm. These experiments were repeated three 
times independently with similar results. 
 
 
Supplementary Figure 4. Phosphorescence spectra of complex 1 in air or 
nitrogen-saturated acetonitrile and in PBS at 293 K. Excitation 405 nm. These 
experiments were repeated three times independently with similar results. 
 
 
 
Supplementary Figure 5. Left: Phosphorescence decay curves of complex 1 in 
N2-saturated or air-saturated acetonitrile and PBS at 293 K. Right: Phosphorescence 
lifetime spectra of complex 1 in PBS in the presence and absence of NADH. These 
experiments were repeated three times independently with similar results. 
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Supplementary Figure 6. Spatial plots of selected frontier orbitals of the DFT 
optimized ground state of complex 1 (from a single point calculation with 
CPCM/CH2Cl2). 
 
 
Supplementary Figure 7. Left: Two-photon absorption (TPA) cross-sections of 
complex 1 in methanol at excitation wavelengths between 700 and 800 nm. Right: 
plot of log intensity versus log power showing quadratic dependence of two photon 
absorption. These experiments were repeated twice independently with similar results. 
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Supplementary Figure 8. Dark stability of complex 1 in a d6-DMSO stock solution 
monitored by 400 MHz 1H NMR spectroscopy at 293 K. These experiments were 
repeated five times independently with similar results. 
 
 
Supplementary Figure 9. Stability of 1 in human serum. (a) High performance liquid 
chromatography (HPLC) traces (254 nm) for analysis of complex 1 (20 μM) stability 
in human serum at t = 0, 2 and 24 h. Diazepam was used as internal standard. Ratios 
of peak area of diazepam/1 are given with the UV traces. Complex 1 remains stable 
and did not interact significantly with the blood proteins even after 24 h. (b) UV-vis 
traces of complex 1 in human serum from 0 to 24 h indicating its prolonged stability. 
These experiments were repeated twice independently with similar results. 
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Supplementary Figure 10. Cyclic voltammogram of complex 1 in N2-saturated 
acetonitrile containing 0.10 M (n-Bu)4NPF6, recorded at 0.10 V/s using a three 
electrode system. Potentials are referenced to SCE via an internal ferrocene standard 
(Fc/Fc+= 0.40 V). These experiments were repeated three times independently with 
similar results. 
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Supplementary Figure 11. DFT-optimized structure for the ground state of 1. The 
calculated bond lengths are listed in Table S6. 
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Supplementary Figure 12. Catalytic photo-oxidation of NADH (3 mM) by complex 
1 (0.25 mM) in H2O/D2O/d4-CD3OD (0.5/49.5/50, v/v) containing NaCl (4 mM), in 
the dark or on irradiation with 463 nm blue light for 10 min. The spectra were 
monitored by 400 MHz 1H NMR spectroscopy at 293 K. Peaks labelled with blue 
triangles represent NADH and peaks labelled with red diamonds represent NAD+. 
After irradiation, the disappearance of blue triangle peaks and appearance of red 
diamond peaks confirmed conversion of NADH to NAD+. These experiments were 
repeated five times independently with similar results. 
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Supplementary Figure 13. UV-vis spectra for the photocatalytic oxidation of NADH 
(240 M) by complex 1 (6 M) in PBS at 293 K.  
NADH stability: (a) NADH alone in the dark for 30 min. The spectrum did not change, 
confirming the high dark stability of NADH. (b) NADH alone under continuous 463 
nm blue light irradiation. The spectra remained almost unchanged, showing that 
NADH was not oxidized during irradiation.  
Dark catalytic reaction: (c) UV-vis spectra of NADH in presence of complex 1 in the 
dark for 30 min. The spectrum of NADH showed no significant change indicating no 
NADH oxidation in the dark. (d) UV-vis spectra of complex 1 in presence of NADH 
in the dark. The spectrum remained unchanged indicating that complex 1 did not react 
with NADH in the dark.  
Photo catalytic reaction: (e) UV-vis spectra of NADH in presence of complex 1 in 
deionized water under continuous 463 nm light irradiation. The decrease of 
absorbance at 339 nm shows that complex 1 has similar NADH photo-catalytic 
oxidative activity in deionized water as in PBS. (f) UV-vis spectra of NADH in PBS 
in presence of complex 1 and 1 mM NaN3. The significant decrease of absorbance at 
339 nm shows that photo-catalytic oxidation of NADH is not induced by singlet 
oxygen since NaN3 is an efficient singlet oxygen inhibitor. These experiments were 
repeated five times independently with similar results. 
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Supplementary Figure 14. Mass spectra (negative mode) monitoring the 
photocatalytic oxidation of NADH (240 M) by complex 1 (6 M) in deionized water 
upon 463 nm light irradiation at 293 K. These data confirm the generation of NAD+ 
after irradiation. These experiments were repeated five times independently with 
similar results. 
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Supplementary Figure 15. Concentration dependence of photo-catalytic reaction of 
NADH with complex 1 (6 M) in PBS at 293 K, monitored by UV-vis spectroscopy. a) 
Time dependence of NADH absorption at 339 nm. b) Plots of lnA339 against time, 
suggesting NADH oxidation follows pseudo first-order kinetics (large excess of 
NADH). c) Plots of the TON against time. d) Dependence of TOF on NADH 
concentration. With increasing NADH/1 ratio, the TOF increased. These experiments 
were repeated three times independently with similar results. 
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Supplementary Figure 16. Long-term (120 min) photocatalytic oxidation of NADH 
(120 M) by complex 1 (0.6 M) monitored with UV-vis spectroscopy. a) Time 
dependence of NADH absorption at 339 nm. b) Plots of lnA339 against time suggest 
that conversion of NADH exhibits first-order kinetics. c) Plots of the TON against 
time with a large excess of NADH. d) Time dependence of the TOF. During long-term 
irradiation, complex 1 exhibits excellent photostability since the TON increased 
linearly with with extension of irradiation time. The TOF decreased slightly during 
irradiation due to the depletion of NADH. During long-term photocatalysis, complex 
1 exhibited extremely high photo stability and TOF (2 h; Fig. S16). The slight 
decrease in TOF at the end of irradiation was due to consumption of NADH substrate. 
These experiments were repeated three times independently with similar results. 
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Supplementary Figure 17. pH change during the reaction of NADH (240 M) with 
complex 1 (6 M) in deionized water at 293 K, in the dark and during irradiation with 
463 nm blue light. These experiments were repeated three times independently with 
similar results. 
 
 
 
 
Supplementary Figure 18 X-band EPR spectra of a solution containing complex 1 
(500 M) and DMPO (10 mM) in methanol and PBS (1:1, v/v) in the presence or 
absence of NADH (5 m M) after irradiation with 463 nm light for 10 min. The 
DMPO-CH3 signal was trapped only after irradiation indicating that H2O2 is a 
photocatalytic product. No peaks were observed in the absence of NADH. These 
experiments were repeated three times independently with similar results. 
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Supplementary Figure 19. Top: X-band EPR spectra of 1O2 trapped by TEMP as 
TEMP-1O2 radicals (N = 16.12G) in acetonitrile. Bottom: Determination of the 
quantum yield for singlet oxygen generation by complex 1 in PBS solution (left) and 
in acetonitrile (right) under 463 nm continuous irradiation. The quantum yield was 
further determined by an indirect method in both PBS (left) and acetonitrile (right). 
The quantum yield in acetonitrile ( = 0.71) is 7x higher than in PBS ( = 0.11). The 
low quantum yield in PBS is due to the lower phosphorescence quantum yield and 
shorter lifetime in water than in acetonitrile. These experiments were repeated three 
times independently with similar results. 
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Supplementary Figure 20. Top: UV-vis spectra of NADH (180 M) and complex 1 
(6 M) in PBS solution under nitrogen during 460 nm light irradiation at 293 K. 
Bottom: Comparison between NADH photocatalytic oxidation under nitrogen and in 
air. Under nitrogen, the NADH oxidation rate decreased significantly compared with 
air. A small amount of NADH was oxidized under nitrogen, showing the high 
oxidative excited state nature of complex 1 and electron transport from NADH to 
complex 1 as the first step of this photoredox catalytic reaction. These experiments 
were repeated three times independently with similar results. 
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Supplementary Figure 21. Photocatalytic reduction of oxidized Fe3+-cyt c (11.2 M) 
by NADH (50 M) and complex 1 (0.6 M) under various conditions. Light 
irradiation: 463 nm. These experiments were repeated three times independently with 
similar results. 
 
 
 
Supplementary Figure 22. Photo-reduction of Fe3+-cyt c (11.2 M) by complex 1 
(0.6 M, 463 nm) or [Ir(tpy)2]3+ (0.6 M, 365 nm) in the presence of NADH (50 M), 
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and effect of the radical trapping agent CYPMPO (120 M). These experiments were 
repeated three times independently with similar results. 
 
 
 
Supplementary Figure 23. Dose-response curves for dark- and photo-toxicity of 
complex 1 against different cancer cell lines under normoxia (a, 20% O2) and hypoxia 
(b, 1% O2). All the experiments were performed as duplicates of triplicates (n=6 
biologically independent experiments). The error bars are ±1 S.D. from the mean. 
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Supplementary Figure 24. Dose-response curves for dark- and photo-toxicity of (a) 
cisplatin, and (b) 5-ALA towards various cancer cell lines under normoxia (20% O2) 
and hypoxia (1% O2). All the experiments were performed as duplicates of triplicates 
(n=6 biologically independent experiments). The error bars are ±1 S.D. from the 
mean. 
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Supplementary Figure 25. Dose-response curves for dark- and photo-toxicity of 
complex 1 towards the A549 cancer cell line in the presence of different ROS 
inhibitors under normoxia (20% O2) and hypoxia (1% O2). All the experiments were 
performed as duplicates of triplicates (n=6 biologically independent experiments). 
The error bars are ±1 S.D. from the mean. 
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Supplementary Figure 26. Dose response curves for dark- and photo-toxicity of 
cisplatin, complex 1 and 5-ALA towards (a) MRC-5 normal lung cells, and (b) LO2 
normal liver cells under normoxia (20% O2). All the experiments were performed as 
duplicates of triplicates (n=6 biologically independent experiments). The error bars 
are ±1 S.D. from the mean. 
 
 
 
Supplementary Figure 27. Dose-response curves for dark- and photo-toxicity of 
cisplatin, complex 1, and 5-ALA towards A549 lung cancer spheroids (ca. 800 m in 
diameter). All the experiments were performed as duplicates of triplicates (n=6 
biologically independent experiments). The error bars are ±1 S.D. from the mean. 
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Supplementary Figure 28. ICP-MS quantification of the internalized Ir in A549 lung 
cancer cells. A549 cells were treated with complex 1 (5 μM) at 310 K for 2 h in the 
dark and the various cell fractions were separated. All the experiments were 
performed as duplicates of triplicates (n=6 biologically independent experiments). 
Error bars show ±1 s.d. from the mean. Statistics were calculated using the two-tailed 
t-test with unequal variances (Welch’s unpaired t-test). *p < 0.05, **p < 0.01 ***p < 
0.001. p values: mitochondria = 0.0044, cytoplasm = 0.0058. 
 
 
 
Supplementary Figure 29. Phosphorescence lifetime histogram of complex 1 in 
A549 cancer cells. Excitation at 760 nm with a pulsed laser. These experiments were 
repeated twice independently with similar results. 
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Supplementary Figure 30. Formazan formation in A549 lung cancer cells. The cells 
were treated with complex 1 (3 M, 2 IC50) for 2 h, followed by washing and 
replacing with fresh cell culture medium, and then irradiated (463 nm, 8.9 J/cm2) or 
kept in the dark under normoxia. Cells were left to recover for 46 h before adding 
MTT. Control: without drug treatment. NAD(P)H-dependent cellular oxidoreductase 
enzymes in mitochondria of living cells are capable of reducing MTT to purple 
insoluble formazan. Formazan is generated in A549 cells treated with complex 1 in 
the dark similarly to untreated cells. For the cells receiving irradiation, the formation 
of formazan reduced significantly, attributable to photocatalytic NADH depletion by 
complex 1. These experiments were repeated three times independently with similar 
results. 
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Supplementary Figure 31. Complex 1 generates ROS in A549 cancer cells after light 
irradiation under normoxia (3 M, 2 light IC50) and hypoxia (5 M, 2 light IC50). 
The cells were treated with complex 1 for 2 h, washed and then irradiated with 463 
nm light under normoxia (20% O2, 8.9 J/cm
2) and 450 nm light under hypoxia (1% O2, 
10.0 J/cm2). After irradiation, cells were stained with DCFH-DA for 0.5 h at 310 K 
and then imaged by inverted fluorescence microscopy (Zeiss, Germany). Excitation 
wavelengths: 488 nm, emission filter: 52020 nm. In the absence of light, the cells 
were not stimulated by complex 1 since only weak ROS signals could be observed. 
After light irradiation, complex 1 effectively generates ROS in A549 cancer cells 
under both normoxia and hypoxia. Non-fluorescent DCFH-DA is transformed into 
green fluorescent DCF after reaction with ROS in cells. These experiments were 
repeated three times independently with similar results. 
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Supplementary Figure 32. ROS generation in multicellular A549 cancer spheroids 
(MCS) treated with complex 1 (2 M) after two-photon light irradiation. Excitation 
wavelengths: complex 1 760 nm; DCF 488 nm, emission filter: 56520 nm (complex 
1), 52020 nm (DCF). In contrast to the normal adherent cultured cancer cells, MCS 
are 3D cell aggregates which mimic the microenvironment of solid tumours in vivo 
(hypoxia core and nutrition gradient). The green ROS signal appeared only in the 
outer region of the spheroids, while became extremely low in intensity in the inner 
portion of A549 MCS, illustrating hypoxic core formation at the centre of the 
spheroids. These experiments were repeated three times independently with similar 
results. 
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Supplementary Figure 33. Determination of mitochondrial membrane potentials for 
A549 cancer cells treated with complex 1 (2 IC50, 3 M under normoxia and 5 M 
under hypoxia) for 2 h, which then received irradiation followed by staining with JC-1. 
The cationic dye JC-1 exhibits potential-dependent accumulation in mitochondria. At 
low MMP, JC-1 emits green fluorescence while at high MMP, the dye emits red 
fluorescence. After irradiation under normoxia and hypoxia, both normoxic and 
hypoxic cells treated with complex 1 emitted strong green fluorescence indicating 
significant mitochondria depolarization, while the cells without irradiation emit red 
fluorescence similar to the control (untreated) samples. JC-1 was excited at 488 nm 
with 530 nm and 585 nm bandpass emission filters. These experiments were repeated 
three times independently with similar results. 
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Supplementary Figure 34. Unaltered mitochondrial membrane potentials in MRC-5 
normal cells on treatment with complex 1 in the dark, determined by JC-1 staining. 
MRC-5 normal cells were incubated with complex 1 (10 M) under normoxia for 2 h 
followed by staining with JC-1. JC-1 was excited at 488 nm, with 530 nm and 585 nm 
bandpass emission filters. These experiments were repeated three times independently 
with similar results. 
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Supplementary Figure 35. Apoptosis of A549 cells under normoxia and hypoxia 
photo-induced by complex 1 detected by Annexin V/PI staining. A549 cancer cells 
were treated with complex 1 (2 light IC50, 3 M under normoxia and 5 M under 
hypoxia) for 2 h, then washed, and irradiated under normoxia (20% O2, 463 nm, 8.9 
J/cm2) or hypoxia (1% O2, 450 nm, 10.0 J/cm
2), followed by recovery for 6 h. In the 
absence of light or drug treatment, no significant fluorescence was observed. After 
light irradiation, cancer cells growing under normoxia or hypoxia exhibited green and 
red fluorescence, indicating severe cell apoptosis and necrosis induced by complex 1. 
These experiments were repeated three times independently with similar results. 
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Supplementary Figure 36. Response to the immunogenic-apoptotic cell death 
mechanism in A549 cancer cells. Cells were treated with complex 1 (3 M) or 
cisplatin (200 M) or oxaliplatin (200 M) at 310 K for 2 h, washed and irradiated 
with 450 nm light (10 J/cm2) followed by recovery for 12 h. (a) Immunofluorescence 
of calreticulin was detected with Alexa Fluor 488-linked–calreticulin antibody. 
Excitation/emission: 488/520 nm. These experiments were repeated three times 
independently with similar results. (b) Enzyme-linked immunosorbent assay (ELISA) 
for high mobility group box 1 protein (HMGB1). The amount of HMGB1 released to 
the outside of the cells was detected by the HMGB1 ELISA kit. All the experiments 
were performed as duplicates of triplicates (n=6 biologically independent experiments). Error 
bars show ±1 s.d. from the mean. Statistics were calculated using the two-tailed t-test 
with unequal variances (Welch’s unpaired t-test). *p < 0.05, **p < 0.01 ***p < 0.001. p 
values 0.5 µM (p = 0.0045), 1.0 µM (p = 0.0005), 2.0 µM (p = 0.0004). 
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